 |
 |
|
|
|
| Stanozolol |
 |
| C21H32N2O.crystal powder |
 |
| 10418-03-8 |
 |
Pharmaceutical raw material
1.Clinic for the treatment of a variety of diseases involving blood vessels.
2.Can be used for chronic wasting disease, osteoporosis, and growth hormone treatment of Turner syndrome
|
 |
| white or off-white crystal powder. odorless. |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
